Membership includes all the major nuclear medicine tracer companies as well as the equipment manufacturers and a few contrast media players. Admission of new Members shall be by resolution of the Members of the Grouping in accordance with Article 11 (xi) (e) from Nuclear Medicine Europe statutes.
Each and every member shall be a company or firm within the meaning of the second paragraph of Article 58 of the Treaty of Rome, and shall be active in the field of Medical Imaging and/or of Nuclear Medicine. A company cannot be a member if it has an interest of 50 % or more in the capital of another member company or if its capital is owned at the rate of 50 % or more by another member company.
If you are interested in joining the Nuclear Medicine Europe membership, please contact us directly :
“Nuclear Medicine Europe” – “NMEU” European Economic Interest Grouping (EEIG)
Avenue Louise 65, box 11 – 1050 Brussels (Belgium) Registration number:0443.242.686
Coordinated version after GA of 25th June 2021
The term “Nuclear Medicine” shall mean medical activity using radioactive substances and/or related compounds. The term “Medical Imaging” shall mean medical activity aiming at the identification of anatomic and / or functional structures.
The term “Regulation” shall mean Council Regulation (EEC) No. 2137/85 of July 25, 1985 on the European Economic Interest Grouping (EEIG).
The term “Grouping” shall mean “Nuclear Medicine Europe” (“NM-EU”) EEIG. (GA 22.05.2019)